Peptide Preparations

Tirzepatide 30mg

Properties:Tirzepatide is a weekly preparation, usually injected once a week, for the treatment of type 2 diabetes and weight loss. Its dual mechanism makes it an ideal choice for patients with high requirements for blood sugar and weight control.
Shape:Irregular
Molecular Weight:4813.45 Grams (g)
CAS No:2023788-19-2
Usage:1) Blood sugar control in type 2 diabetes: Tirzepatide significantly lowers blood sugar levels by activating GLP-1 and GIP receptors. It can stimulate insulin secretion, inhibit glucagon release, and delay gastric emptying, thereby effectively improving blood sugar control in patients with type 2 diabetes. It is suitable for patients who still cannot achieve ideal blood sugar control through diet, exercise and oral hypoglycemic drugs (such as metformin or sulfonylureas). 2) Weight management: Tirzepatide performs well in weight management, especially for obese or overweight patients with weight-related comorbidities (such as hypertension, dyslipidemia, hyperglycemia, etc.). It helps patients lose weight by increasing satiety, reducing appetite and delaying gastric emptying. Clinical studies have shown that Tirzepatide can significantly reduce body mass index (BMI) and improve metabolic status. 3) Improvement of cardiovascular health: Tirzepatide also has a positive effect on the cardiovascular system. It can reduce the risk of cardiovascular disease and improve blood pressure and blood lipid levels, thereby providing additional health benefits for diabetic patients. 4) Other potential applications: Although the main indications of Tirzepatide are type 2 diabetes and weight management, it also shows certain potential in the fields of neurological diseases (such as Alzheimer's disease, Parkinson's disease), skin repair, tumor treatment, etc. However, these applications still need further research and clinical trial verification.
Ingredients:Tirzepatide
Appearance:White or almost white powder
Supply Ability:1000 Per Week

Price: 160.0 USD ($)/Box

Send Inquiry

Retatrutide 5mg/10mg/15mg/20mg/30mg

Supply Ability:500 Per Week
Properties:1) Triple receptor agonism: Retatrutide is a GGG triple agonist that can act on three receptors simultaneously: glucagon-like peptide-1 receptor (GLP-1R), gastric inhibitory peptide receptor (GIPR) and glucagon receptor (GCGR). This triple mechanism of action makes it excellent in controlling appetite, delaying gastric emptying and increasing energy expenditure. 2) Significant weight loss effect: Clinical trials have shown that Retatrutide is effective in weight loss. At the highest dose, participants lost an average of 24.2% weight in 11 months, which is far superior to the 15-20% weight loss effect of other GLP-1 receptor agonists currently on the market (such as Semaglutide and Tirzepatide). 3) Metabolic regulation: Retatrutide can not only effectively reduce weight, but also improve metabolic indicators. For example, it can significantly reduce glycosylated hemoglobin (HbA1c) levels and has a positive effect on blood sugar control in patients with type 2 diabetes. In addition, it may also have a beneficial effect on cardiovascular health, although this area still needs further research. 4) Long-term effect and convenience: Retatrutide has been modified by fatty acid acylation and can bind to albumin in the blood, thereby extending its half-life. This means that patients only need to inject once a week, which is more convenient to use.
Shape:Irregular
Molecular Weight:4730.91 Grams (g)
Appearance:White or almost white powder
CAS No:2381089-83-2
Usage:1) Obesity Treatment: In the Phase II clinical trial, patients in the highest dose group (12 mg) lost an average of 24.2% weight after 48 weeks, and some patients lost more than 30%. 2) Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD): Retatrutide can reduce liver fat content by 86%, and more than 85% of patients achieve regression of liver steatosis. 3) Type 2 Diabetes: Significantly reduce glycated hemoglobin (HbA1c) and improve blood sugar control. 4) Potential Cardiovascular Benefits: Animal studies have shown that it may indirectly protect cardiovascular health by improving blood pressure and heart function, but further clinical verification is needed.
Ingredients:Retatrutide

Price: 100.0 USD ($)/Box

Send Inquiry

Cathelicidin LL-37 (Human)

Molecular Formula:C205H340N60O53
Product Type:Lyophilized Powder
Smell:Other
Shelf Life:24 Months
Poisonous:NO
Application:Pharmaceutical
Grade:Reagent Grade
Supply Ability:5000 Per Week

Price: 8.6 USD ($)/Piece

Send Inquiry

Thymosin Alpha 1 (Thymalfasin)

Solubility:Insoluble in acetonitrile, ether and chloroform, slightly soluble in water, soluble in trifluoroacetic acid
Storage:Freezer
Purity: 99.0%
Taste:Other
Application:Pharmaceutical
Grade:Reagent Grade
Physical Form:Powder
Supply Ability:5000 Per Week

Price: 2.75 USD ($)/Piece

Send Inquiry

Bremelanotide (PT-141)

Ingredients:Bremelanotide
CAS No:1607799-13-2
Usage:1) Indications: PT-141 is mainly used to treat female hypoactive sexual desire disorder (HSDD), especially premenopausal women. It was approved by the US FDA on June 21st, 2019, with the trade name Vyleesi , and the dosage form is subcutaneous injection. Efficacy Characteristics: Clinical trials show that its efficacy peaks about 4 hours after injection, can quickly stimulate sexual desire, and is non-addictive.
Appearance:White powder
Molecular Weight:1025.16
Properties:PT-141 (also known as bremelanotide) is a melanocortin receptor agonist that primarily acts on melanocortin receptor type 4 (MC4R), which is present in the central nervous system (CNS) and regulates functions such as appetite, sexual behavior, and skin pigmentation. Chemical Properties: PT-141 is a cyclic peptide that is highly soluble in water and has a pKa value of 7.3. Its molecular formula is C50H68N14O10 and its molecular weight is 1025.163. PT-141 is a white powder with a melting point of approximately 150 C and a density of 1.4 0.1 g/cm3. Biological Activity: PT-141 is an analog of -melanocyte stimulating hormone ( -MSH) that activates mPOA in the central nervous system and other hypothalamic and limbic areas of the brain involved in sexual behavior. It is primarily used to study Hypoactive Sexual Desire Disorder(HSDD). In addition, PT-141 also has the effect of stimulating the production and secretion of melanin.
Product Type:Lyophilized Powder
Supply Ability:5000 Per Week